References
- ShiPGustafsonJAMacKayJAGenetically engineered nanocarriers for drug deliveryInt J Nanomedicine201491617162624741309
- SharmaAJainNSareenRNanocarriers for diagnosis and targeting of breast cancerBiomed Res Int2013201396082123865076
- FayFScottCJAntibody targeted nanoparticles for cancer therapyImmunotherapy20113338139421395380
- SchroederRLStevensCLSridharJSmall molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancerMolecules2014199151961521225251190
- Cirstoiu-HapcaABucheggerFLangeNBossyLGurnyRDelieFBenefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in miceJ Control Release2010144332433120219607
- SunBRanganathanBFengSSMultifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancerBiomaterials200829447548617953985
- YangTChoiMKCuiFDAntitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cellsPharm Res200724122402241117828616
- PatriAKKukowska-LatalloJFBakerJRJrTargeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complexAdv Drug Deliv Rev200557152203221416290254
- ChengYXuZMaMXuTDendrimers as drug carriers: applications in different routes of drug administrationJ Pharm Sci200897112314317721949
- JainADubeySKaushikATyagiAKDendrimer: a complete drug carrierInt J Pharm Sci Drug Res2010143852
- SvensonSChauhanASDendrimers for enhanced drug solubilizationNanomedicine (Lond)20083567970218817470
- MajorosIJ1MycAThomasTMehtaCBBakerJRJrPAMAM dendrimer-based multifuntional conjugate for cancer therapy: synthesis, characterization, and functionalityBiomacromolecules20057257257916471932
- WangWXiongWWanJSunXXuHYangXThe decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stressNanotechnology2009201010510319417510
- HermansonGreg TBioconjugate_Techniques-2nd_edtion2008
- LeeJHNanACombination drug delivery approaches in metastatic breast cancerJ Drug Deliv2012201291537522619725
- KaminskasLMMcLeodVMPorterCJBoydBJAssociation of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulationMol Pharm2012935537322250750
- ClineENLiM-HChoiSKPaclitaxel-conjugated PAMAM dendrimers adversely affect microtubule structure through two independent modes of actionBiomacromolecules201314365466423391096
- YellepeddiVKPisalDSKumarAPermeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayersInt J Pharm200835011312117913410
- LuoDHaverstickKBeichevaNHanESaltzmanWMPoly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA DeliveryMacromolecules20083534563462
- QiRGaoYTangYPEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expressionAAPS J200911339540519479387
- ThomasPTShuklaRKotlyarADendrimer-epidermal growth factor conjugate displays superagonist activityBiomacromolecules20079260360918193839
- PatriAKMycABealsJThomasTPBanderNHBakerJRJrSynthesis and in vitro testing of J591 antbody-denderimer conjugates for targeted prostate cancer therapyBioconjug Chem2004151174118115546182
- PimphaNChaleawlert-umponSChruewkamlowNKasinrerkWPreparation of anti-CD4 monoclonal antibody-conjugated magnetic poly(glycidyl methacrylate) particles and their application on CD4+ lymphocyte separationTalanta2011841899721315903
- DavisMEChenZShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
- SawantRRTorchilinVPChallenges in development of targeted liposomal therapeuticsAAPS J201214230331522415612
- JinJSuiBGouJPSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cellsPLoS One2014911112
- Vicente-AliqueENúñez-RamírezRVegaJFHuPMartínez-SalazarJSize and conformational features of ErbB2 and ErbB3 receptors: a TEM and DLS comparative studyEur Biophys J201140783584221476053
- JulienDCBehnkeSWangGMurdochGKHillRAUtilization of monoclonal antibody-targeted nanomaterials in the treatment of cancerMAbs20113546747821814040
- ZhuSHongMZhangLTangGJiangYPeiYPEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulationPharm Res201027116117419862607
- ZhengNDaiWDuWA novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptorsMol Pharm2012951175118822435704
- HussainAFKrügerHRKampmeierFTargeted delivery of dendritic polyglycerol-doxorubicin conjugates by scFv-SNAP fusion protein suppresses EGFR+ cancer cell growthBiomacromolecules20131482510252023782069
- YuYWangZHZhangLMitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanomaBiomaterials20123361808182022136714
- MenjogeARKannanRMTomaliaDADendrimer-based drug and imaging conjugates: design considerations for nanomedical applicationsDrug Discov Today2010155–617118520116448